ACTRN12616001180404Completed未知
An observational study of the performance characteristics including Sensitivity and NPV of the Cxbladder urine test in patients undergoing intravesical therapy (BCG treatment) Mitomycin C (MMC) therapy as treatment for urothelial carcinoma.
Pacific Edge Diagnostics Pty Ltd0 sites50 target enrollmentStarted: August 29, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 85 Years (—)
- Sex
- All
Inclusion Criteria
- •Men and women between 18 and 85 years undergoing BCG or Mitomycin C (MMC) therapy for urothelial carcinoma or DMSO/heparin therapy for painful bladder syndrome at Concord Hospital.
- •The study invites patients undergoing DMSO/heparin therapy as a control group - The Cxbladder results from these patients are compared against those for the BCG or Mitomycin C (MMC) therapy patients.
Exclusion Criteria
- •Patients declining involvement in the study and patients with obvious active urinary tract infections.
Investigators
Similar Trials
Completed
Not Applicable
An observational study of the efficacy of the Cxbladder a urine test for the detection of urothelial carcinoma in patients presenting with macroscopic or microscopic haematuria.Bladder cancerACTRN12616001181493Pacific Edge Diagnostics Pty Ltd300
Recruiting
Not Applicable
An observational study of the uRNA-2 urine test for the monitoring of recurrence of urinary tract transitional cell carcinoma (TCC)Bladder CancerCancer - BladderACTRN12612000042842Pacific Edge PTY Ltd.300
Not yet recruiting
Not Applicable
Evaluation of machine learning model for auto assessment of cervical health using Smart ScopeCTRI/2019/09/021261Periwinkle Technologies Pvt Ltd
Active, not recruiting
Unknown
A study aiming at showing the performance and safety of the Eagle device by collecting data from patients being treated for glaucoma or eye hypertension with the Eagle deviceGlaucoma and ocular hypertensionEye DiseasesISRCTN16769682BELKIN Vision Ltd.550
Recruiting
Not Applicable
A pilot observational study of the uRNA-2 urine test for the detection of urinary tract transitional cell carcinoma (TCC) in patients under a schedule of investigative cystoscopies for monitoring of recurrent TCC.Bladder CancerACTRN12612000043831Pacific Edge Ltd100